DL-2-Amino-2-(4-bromophenyl)acetic acid

Catalog No. :
ACISXT891
CAS No. :
71079-03-3
Molecular Formula :
C8H8BrNO2
Molecular Weight :
230.06

IUPAC Name:2-amino-2-(4-bromophenyl)acetic acid

DL-2-Amino-2-(4-bromophenyl)acetic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$125.00Login to see priceIn stockInquiry
10g97%$238.00Login to see priceIn stockInquiry
25g97%$469.00Login to see priceIn stockInquiry
100g97%$1624.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameDL-2-Amino-2-(4-bromophenyl)acetic acid
IUPAC Name2-amino-2-(4-bromophenyl)acetic acid
MDL No.MFCD00049327
Molecular FormulaC8H8BrNO2
Molecular Weight230.06
SMILESNC(C(=O)O)C1=CC=C(C=C1)Br
InChI KeyAPLQICUORRMFHY-UHFFFAOYSA-N
Synonym2-amino-2-(4-bromophenyl)acetic Acid | 71079-03-3 | 129592-99-0 | 119397-06-7 | amino(4-bromophenyl)acetic acid | MFCD00049327 | 2-Amino-2-(4-bromophenyl)aceticacid | (+)-2-Amino-2-(4-bromophenyl)acetic acid | 2-Amino-2-(4-Bromophenyl)Acetic | Amino-(4-bromo-phenyl)-acetic
CAS No.71079-03-3
PubChem CID2764157

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACISXT891 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  2. Plus
  3. ACOALG149 route compound structure diagram
    ACOALG1497099-87-8 In Stock
  4. Then
  5. ACISXT891 route product structure diagram
    ACISXT89171079-03-3 In Stock
Inquiry

2. ACISXT891 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXSBO059 route compound structure diagram
    ACXSBO059917925-71-4 In Stock
  2. Then
  3. ACISXT891 route product structure diagram
    ACISXT89171079-03-3 In Stock
Inquiry

Comments (0)